Company
Abalone Bio
We create antibodies that activate hard-to-drug targets, unlocking therapies with fewer side effects to treat more people, more effectively.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- pharmaceutical companies
- abalonebio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
Abalone Bio is a preclinical-stage biotech company developing antibody drugs for GPCRs, ion channels and other membrane protein targets
Loading relationship preview